Our new operating structure represents the next steps in Pfizer's journey to further revitalize our innovative core, enhance the value of our consumer and off-patent established brands and maximize the use of our capital to deliver value to patients and our shareholders. Through this evolution, we are enabling greater independence, focus and responsiveness for our commercial businesses.
Innovative
Pharma Business
Established
Pharma
Business
Vaccines, Oncology
and Consumer
Healthcare Business
Research &
Development
Global Supply
Functions